(7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptatriaconta-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide

C77H135NO18 — CID 165324421

IUPAC(7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptatriaconta-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CCCCCCCCCCCCCCCCCCCCCCCCCCCC
InChIInChI=1S/C77H135NO18/c1-3-5-7-9-11-13-15-17-19-21-23-24-25-26-27-28-29-30-31-32-33-34-35-37-38-40-42-44-46-48-50-52-54-61(82)60(78-65(83)55-53-51-49-47-45-43-41-39-36-22-20-18-16-14-12-10-8-6-4-2)59-91-75-71(89)68(86)73(63(57-80)93-75)96-77-72(90)69(87)74(64(58-81)94-77)95-76-70(88)67(85)66(84)62(56-79)92-76/h6,8,12,14,18,20,36,39,43-46,52,54,60-64,66-77,79-82,84-90H,3-5,7,9-11,13,15-17,19,21-35,37-38,40-42,47-51,53,55-59H2,1-2H3,(H,78,83)/b8-6-,14-12-,20-18-,39-36-,45-43-,46-44+,54-52+
InChIKeyXSXIKLVPHXWOOW-COWGTEELSA-N
MW1362.92 g/mol
LogP11.44
Rot. Bonds58

About (7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptatriaconta-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide

(7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptatriaconta-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide (PubChem CID 165324421) has the molecular formula C77H135NO18 and a molecular weight of 1362.92 g/mol. Its IUPAC name is (7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptatriaconta-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide.

Molecular Properties

Compound Name(7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptatriaconta-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide
PubChem CID165324421
Molecular FormulaC77H135NO18
Molecular Weight1362.92 g/mol
Exact Mass1361.97
IUPAC Name(7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptatriaconta-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CCCCCCCCCCCCCCCCCCCCCCCCCCCC
InChIInChI=1S/C77H135NO18/c1-3-5-7-9-11-13-15-17-19-21-23-24-25-26-27-28-29-30-31-32-33-34-35-37-38-40-42-44-46-48-50-52-54-61(82)60(78-65(83)55-53-51-49-47-45-43-41-39-36-22-20-18-16-14-12-10-8-6-4-2)59-91-75-71(89)68(86)73(63(57-80)93-75)96-77-72(90)69(87)74(64(58-81)94-77)95-76-70(88)67(85)66(84)62(56-79)92-76/h6,8,12,14,18,20,36,39,43-46,52,54,60-64,66-77,79-82,84-90H,3-5,7,9-11,13,15-17,19,21-35,37-38,40-42,47-51,53,55-59H2,1-2H3,(H,78,83)/b8-6-,14-12-,20-18-,39-36-,45-43-,46-44+,54-52+
InChIKeyXSXIKLVPHXWOOW-COWGTEELSA-N
XLogP11.44
TPSA307.01 Ų
H-Bond Donors12
H-Bond Acceptors18
Rotatable Bonds58
Heavy Atoms96
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001362.92
LogP ≤ 511.44
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptatriaconta-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptatriaconta-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide?
The IUPAC name of (7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptatriaconta-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide (CID 165324421) is (7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptatriaconta-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide.
What is the SMILES notation for (7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptatriaconta-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide?
The canonical SMILES for (7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptatriaconta-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide is CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CCCCCCCCCCCCCCCCCCCCCCCCCCCC.
What is the InChIKey of (7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptatriaconta-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide?
The InChIKey is XSXIKLVPHXWOOW-COWGTEELSA-N. The full InChI is InChI=1S/C77H135NO18/c1-3-5-7-9-11-13-15-17-19-21-23-24-25-26-27-28-29-30-31-32-33-34-35-37-38-40-42-44-46-48-50-52-54-61(82)60(78-65(83)55-53-51-49-47-45-43-41-39-36-22-20-18-16-14-12-10-8-6-4-2)59-91-75-71(89)68(86)73(63(57-80)93-75)96-77-72(90)69(87)74(64(58-81)94-77)95-76-70(88)67(85)66(84)62(56-79)92-76/h6,8,12,14,18,20,36,39,43-46,52,54,60-64,66-77,79-82,84-90H,3-5,7,9-11,13,15-17,19,21-35,37-38,40-42,47-51,53,55-59H2,1-2H3,(H,78,83)/b8-6-,14-12-,20-18-,39-36-,45-43-,46-44+,54-52+.
What are the key properties of (7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptatriaconta-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide?
(7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptatriaconta-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide has a molecular weight of 1362.92 g/mol, XLogP of 11.44, 58 rotatable bonds, 12 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for (7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptatriaconta-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide is sourced from PubChem (CID 165324421), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).